BOULDER, CO, Ambrosia Biosciences, today announced the successful first closing of its Series A financing.
The financing totaled $16 million, and was led by BVF Partners and Boulder Ventures. Ambrosia's financing will be used to scale up its drug discovery programs and laboratory operations in Boulder, CO.
Ambrosia Biosciences is a privately held drug discovery company developing orally delivered, small molecule-based therapies for obesity and other metabolic disorders.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
